Skip to content
MedsAcross

Medicine

Zaleplon 10 mg capsule

Zaleplon · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIVGeneric name

Zaleplon 10 mg capsule is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Zaleplon
Brand
Sold under the generic name
Strength
10 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 500 capsules, 1000 capsules and 31 more
Manufacturers
Unichem LaboratoriesIndiaAurobindo PharmaIndiaBryant Ranch PrepackPreferred PharmaceuticalsA-S Medication SolutionsPD-Rx PharmaceuticalsBionpharmaHikma PharmaceuticalsRising Pharma Holdings
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIV
ATC code
N05CF03 Zaleplon
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
6 June 2008
Identifiers
RxCUI 313761, 313762DailyMed set ID d58138d1-3378-482c-a401-958dabe1be7d, 2cc7adee-2c4c-4fed-9914-545e70dba773, a1277ef5-6072-43ff-a6ce-0a7cea58b7cb +10NDC 68788-8725, 43063-783, 43063-912 +10Application ANDA090374, ANDA078989, ANDA077237 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle65862-215-01Aurobindo PharmaIndia6 June 2008
500 capsule in 1 bottle65862-215-05Aurobindo PharmaIndia6 June 2008
100 capsule in 1 bottle, plastic29300-132-01Unichem LaboratoriesIndia5 May 2009
500 capsule in 1 bottle, plastic29300-132-05Unichem LaboratoriesIndia5 May 2009
1000 capsule in 1 bottle, plastic29300-132-10Unichem LaboratoriesIndia5 May 2009
100 capsule in 1 bottle69452-365-20Bionpharma17 February 2024
100 capsule in 1 bottle0054-0085-25Hikma Pharmaceuticals6 June 2008
100 capsule in 1 bottle57237-240-01Rising Pharma Holdings6 June 2008
15 capsule in 1 bottle63629-3405-1Bryant Ranch Prepack22 December 2021
30 capsule in 1 bottle63629-3405-2Bryant Ranch Prepack22 December 2021
60 capsule in 1 bottle63629-3405-3Bryant Ranch Prepack26 May 2010
90 capsule in 1 bottle63629-3405-4Bryant Ranch Prepack31 May 2013
15 capsule in 1 bottle71335-1054-1Bryant Ranch Prepack30 May 2024
30 capsule in 1 bottle71335-1054-2Bryant Ranch Prepack10 January 2019
60 capsule in 1 bottle71335-1054-3Bryant Ranch Prepack30 May 2024
90 capsule in 1 bottle71335-1054-4Bryant Ranch Prepack30 May 2024
15 capsule in 1 bottle71335-2468-1Bryant Ranch Prepack16 August 2024
30 capsule in 1 bottle71335-2468-2Bryant Ranch Prepack16 August 2024
60 capsule in 1 bottle71335-2468-3Bryant Ranch Prepack16 August 2024
90 capsule in 1 bottle71335-2468-4Bryant Ranch Prepack16 August 2024
10 capsule in 1 bottle, plastic43063-783-10PD-Rx Pharmaceuticals24 August 2017
10 capsule in 1 bottle, plastic43063-912-10PD-Rx Pharmaceuticals5 December 2018
100 capsule in 1 bottle, plastic68788-7208-1Preferred Pharmaceuticals6 August 2018
20 capsule in 1 bottle, plastic68788-7208-2Preferred Pharmaceuticals6 August 2018
30 capsule in 1 bottle, plastic68788-7208-3Preferred Pharmaceuticals6 August 2018
60 capsule in 1 bottle, plastic68788-7208-6Preferred Pharmaceuticals6 August 2018
90 capsule in 1 bottle, plastic68788-7208-9Preferred Pharmaceuticals6 August 2018
100 capsule in 1 bottle68788-8725-1Preferred Pharmaceuticals16 August 2024
20 capsule in 1 bottle68788-8725-2Preferred Pharmaceuticals16 August 2024
30 capsule in 1 bottle68788-8725-3Preferred Pharmaceuticals16 August 2024
60 capsule in 1 bottle68788-8725-6Preferred Pharmaceuticals16 August 2024
90 capsule in 1 bottle68788-8725-9Preferred Pharmaceuticals16 August 2024
10 capsule in 1 bottle50090-1564-0A-S Medication Solutions22 December 2014
30 capsule in 1 bottle50090-1564-1A-S Medication Solutions22 December 2014

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 13 August 1999Drugs@FDA
EU (EMA)WithdrawnEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Zaleplon

Clinical summary

Zaleplon is a gamma-aminobutyric acid A receptor agonist indicated for the short-term treatment of insomnia. It is available as capsules for oral use. MedsAcross supplies Zaleplon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Zaleplon

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Zaleplon 10 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.